Which countries does the company export to?

Products are exported to more than 80 countries in Asia, Americas, Europe, Oceania, and Africa.

What certifications does the manufacturer hold?

The manufacturer holds ISO GMP certification and produces in strict accordance with GMP requirements.

Paracetamol Injection 100ml: 1g Ma Holder

Name: Paracetamol Injection 100ml: 1g Ma Holder
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 2069610835

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.30-0.40

20,000 Pieces

Sample price:US$1.00/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Intravenous Infusion

Model NO.

100ml: 1g

Suitable for

Elderly, Adult

State

Liquid

Shape

Solution

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

22023397

Certificate

ISO GMP

Transport Package

Carton

Specification

80bottles/carton

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Production Capacity

1000000

Key features

Clear Liquid Formulation: Colorless clear or nearly colorless liquid solution for intravenous infusion.

ISO GMP Certified: Manufactured in strict accordance with ISO GMP requirements for quality assurance.

Global Export Reach: Products exported to over 80 countries across Asia, Americas, Europe, Oceania, and Africa.

Advanced Automation: Production lines feature full automation and information control at international advanced levels.

70-Year Brand History: Shijiazhuang No. 4 Pharmaceutical Co., Ltd. has a 70-year history in the pharmaceutical industry.

Top 100 Enterprise: Ranked among China's top 100 pharmaceutical industry enterprises for consecutive years.

Flexible Payment Terms: Accepts LC and T/T payment methods for international trade.

Comprehensive Product Range: Manufacturer of large volume injections, tablets, capsules, and small volume injections.

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤24hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is identified as a Chinese public pharmaceutical manufacturer based in Hebei, with products spanning infusion solutions, injections, tablets, capsules, inhalation products, and other medical materials. The supplier reports ISO 9001, ISO 14001, and GMP certifications, more than ten production lines, automated and information-based production and logistics processes, and substantial stated output across several dosage forms. Its export activity began in 2002, although exports represent only 1%–10% of total sales. The company describes integrated R&D, manufacturing, and marketing capabilities, but the provided information does not establish specific after-sales programs, customization services, or named customer cases. Financial strength cannot be assessed because financial data is excluded.

Supplier typeThe supplier is explicitly classified as a Manufacturer/Factory and is described as an integrated pharmaceutical enterprise covering R&D, industrial production, and marketing. Its listed business covers health and medicine products, including injections, infusion solutions, tablets, capsules, and related dosage forms.

CertificationsThe supplier reports ISO 9001, ISO 14001, and GMP certifications. It also states that production is organized strictly according to GMP requirements, providing explicit evidence of formal quality, environmental, and pharmaceutical manufacturing systems.

R&D capabilityThe supplier describes an integrated R&D, production, and marketing model, reports 50 R&D engineers, and states that its production lines integrate leading equipment and technology at an international advanced level. This supports established technical and development capability, although no specific patents, new-product results, or R&D investment details are provided.

Production capacityProduction capability is strongly supported by more than ten production lines, automated and information-based production and logistics processes, and stated annual outputs of 1.5 billion large-volume injection units and 1 billion units each for tablets, capsules, and small-volume injections. The company also reports more than ten international advanced infusion-solution lines and exports through both agency and self-operated channels.

Product Q&A

Q:What is the recommended dosage for adults weighing over 50kg?

For adults and teenagers over 13 years old weighing over 50kg, the recommended dose is 1000mg every 6 hours or 650mg every 4 hours. The maximum single dose is 1000mg, and the maximum daily dose is 4000mg.

Q:How should this medication be administered?

It is administered by phleboclysis (intravenous infusion). It can be dosed once or for several repetitive times.

Q:Is dosage adjustment needed when switching from oral to injection?

No, the dosage need not be adjusted when adults and teenagers change from oral Paracetamol to injection by phleboclysis.

Q:What are the payment terms for this product?

The accepted terms of payment are LC (Letter of Credit) and T/T (Telegraphic Transfer).

Q:What is the lead time for orders?

The average lead time is one month during the peak season.